Validation of parametric methods for [11C]PE2I positron emission tomography

NeuroImage

Volumn 74, Issue , 2013, Pages 172-178

  Jonasson, My ^a,b   Appel, Lieuwe ^a,b   Engman, Jonas ^a   Frick, Andreas ^a   Nyholm, Dag ^a   Askmark, Håkan ^a   Danfors, Torsten ^a,b   Sörensen, Jens ^a,b   Furmark, Tomas ^a   Lubberink, Mark ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

11C PE2I; Dopamine transporter; Kinetic modeling; Parametric images; PET; Reference tissue model

Indexed keywords

DOPAMINE TRANSPORTER; N (3 IODOPROP 2 ENYL) 2BETA CARBOXYMETHOXY 3BETA (4 METHYLPHENYL)NORTROPANE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER SIMULATION; CORPUS STRIATUM; DIAGNOSTIC IMAGING EQUIPMENT; FEMALE; GRAY MATTER; HUMAN; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MALE; NEUROIMAGING; PARAMETRIC TEST; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOCIAL PHOBIA; THALAMUS;

ADULT; BRAIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; NORTROPANES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84874976617     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.02.022     Document Type: Article

References (29)

1. Antonini A., Moresco R.M., Gobbo C., De Notaris R., Panzacchi A., Barone P., Calzetti S., Negrotti A., Pezzoli G., Fazio F. The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT. Neurol. Sci. 2001, 22:47-48.
2. DeLorenzo C., Kumar J.S., Zanderigo F., Mann J.J., Parsey R.V. Modeling considerations for in vivo quantification of the dopamine transporter using [(11)C]PE2I and positron emission tomography. J. Cereb. Blood Flow Metab. 2009, 29:1332-1345.
3. Emond P., Guilloteau D., Chalon S. PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter. CNS Neurosci. Ther. 2008, 14:47-64.
4. Gulley J.M., Zahniser N.R. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur. J. Pharmacol. 2003, 479:139-152.
5. Gunn R.N., Lammertsma A.A., Hume S.P., Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage 1997, 6:279-287.
6. Hall H., Halldin C., Guilloteau D., Chalon S., Emond P., Besnard J., Farde L., Sedvall G. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. NeuroImage 1999, 9:108-116.
7. Halldin C., Erixon-Lindroth N., Pauli S., Chou Y.H., Okubo Y., Karlsson P., Lundkvist C., Olsson H., Guilloteau D., Emond P., Farde L. [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. Eur. J. Nucl. Med. Mol. Imaging 2003, 30:1220-1230.
8. Hirvonen J., Johansson J., Teräs M., Oikonen V., Lumme V., Virsu P., Roivainen A., Någren K., Halldin C., Farde L., Hietala J. Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility. J. Cereb. Blood Flow Metab. 2008, 28:1059-1069.
9. Ichise M., Ballinger J.R., Golan H., Vines D., Luong A., Tsai S., Kung H.F. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J. Nucl. Med. 1996, 37:513-520.
10. Ichise M., Liow J.S., Lu J.Q., Takano A., Model K., Toyama H., Suhara T., Suzuki K., Innis R.B., Carson R.E. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 2003, 23:1096-1112.
11. Jucaite A., Fernell E., Halldin C., Forssberg H., Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol. Psychiatry 2005, 57:229-238.
12. Jucaite A., Odano I., Olsson H., Pauli S., Halldin C., Farde L. Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study. Eur. J. Nucl. Med. Mol. Imaging 2006, 33:657-668.
13. Laakso A., Bergman J., Haaparanta M., Vilkman H., Solin O., Syvälahti E., Hietala J. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr. Res. 2001, 52:115-120.
14. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. NeuroImage 1996, 4:153-158.
15. Lammertsma A.A., Bench C.J., Hume S.P., Osman S., Gunn K., Brooks D.J., Frackowiak R.S. Comparison of methods for analysis of clinical [11C]raclopride studies. J. Cereb. Blood Flow Metab. 1996, 16:42-52.
16. Leroy C., Karila L., Martinot J.L., Lukasiewicz M., Duchesnay E., Comtat C., Dollé F., Benyamina A., Artiges E., Ribeiro M.J., Reynaud M., Trichard C. Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study. Addict. Biol. 2012, 17:981-990.
17. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
18. Meyer P.T., Hellwig S., Amtage F., Rottenburger C., Sahm U., Reuland P., Weber W.A., Hüll M. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J. Nucl. Med. 2011, 52:393-400.
19. Odano I., Varrone A., Savic I., Ciumas C., Karlsson P., Jucaite A., Halldin C., Farde L. Quantitative PET analyses of regional [(11)C]PE2I binding to the dopamine transporter - application to juvenile myoclonic epilepsy. NeuroImage 2012, 59:3582-3593.
20. Ribeiro M.J., Vidailhet M., Loc'h C., Dupel C., Nguyen J.P., Ponchant M., Dollé F., Peschanski M., Hantraye P., Cesaro P., Samson Y., Remy P. Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Arch. Neurol. 2002, 59:580-586.
21. Ribeiro M.J., Thobois S., Lohmann E., du Montcel S.T., Lesage S., Pelissolo A., Dubois B., Mallet L., Pollak P., Agid Y., Broussolle E., Brice A., Remy P. A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations. J. Nucl. Med. 2009, 50:1244-1250. Group F.P.s.D.G.S.
22. Seki C., Ito H., Ichimiya T., Arakawa R., Ikoma Y., Shidahara M., Maeda J., Takano A., Takahashi H., Kimura Y., Suzuki K., Kanno I., Suhara T. Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models. Ann. Nucl. Med. 2010, 24:249-260.
23. Slifstein M., Laruelle M. Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J. Nucl. Med. 2000, 41:2083-2088.
24. Spencer T.J., Biederman J., Madras B.K., Faraone S.V., Dougherty D.D., Bonab A.A., Fischman A.J. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol. Psychiatry 2005, 57:1293-1300.
25. Svarer C., Madsen K., Hasselbalch S.G., Pinborg L.H., Haugbøl S., Frøkjaer V.G., Holm S., Paulson O.B., Knudsen G.M. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. NeuroImage 2005, 24:969-979.
26. Warwick J.M., Carey P.D., Cassimjee N., Lochner C., Hemmings S., Moolman-Smook H., Beetge E., Dupont P., Stein D.J. Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram. Metab. Brain Dis. 2012, 27:151-158.
27. Wu Y., Carson R.E. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow Metab. 2002, 22:1440-1452.
28. Yaqub M., Tolboom N., Boellaard R., van Berckel B.N., van Tilburg E.W., Luurtsema G., Scheltens P., Lammertsma A.A. Simplified parametric methods for [11C]PIB studies. NeuroImage 2008, 42:76-86.
29. Yaqub M., Boellaard R., van Berckel B.N., Tolboom N., Luurtsema G., Dijkstra A.A., Lubberink M., Windhorst A.D., Scheltens P., Lammertsma A.A. Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies. Mol. Imaging Biol. 2009, 11:322-333.